Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NOD2 | Q9HC29 | 1/20 | 1.00 |
| ▸ | ESR1 | P03372 | 2/20 | 0.68 |
| ▸ | PGR | P06401 | 2/20 | 0.68 |
| ▸ | HTR1A | P08908 | 1/20 | 0.68 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.68 |
| ▸ | AR | P10275 | 1/20 | 0.68 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.68 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.68 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.68 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.68 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.68 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.60 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
| ▸ | THRB | P10828 | 1/20 | 0.40 |
| ▸ | LGALS3 | P17931 | 1/20 | 0.35 |
| ▸ | SELP | P16109 | 5/20 | 0.34 |
| ▸ | SELL | P14151 | 3/20 | 0.34 |
| ▸ | SELE | P16581 | 3/20 | 0.34 |
| ▸ | ANPEP | P15144 | 2/20 | 0.33 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Muramyldipeptide SCHEMBL20516503 | 1.00 | NOD2 (1.00) | NOD2ESR1PGRHTR1AADORA3 | |
| Muramyl Dipeptide SCHEMBL9770111 | 1.00 | NOD2 (1.00) | NOD2ESR1PGRHTR1AADORA3 | |
| Muramyldipeptide SCHEMBL15263102 | 1.00 | NOD2 (1.00) | NOD2ESR1PGRHTR1AADORA3 | |
| Muramyl Dipeptide SCHEMBL41813 | 1.00 | NOD2 (1.00) | NOD2ESR1PGRHTR1AADORA3 | |
| Muramyldipeptide SCHEMBL19486934 | 1.00 | NOD2 (1.00) | NOD2ESR1PGRHTR1AADORA3 | |
| Muramyldipeptide SCHEMBL20516502 | 1.00 | NOD2 (1.00) | NOD2ESR1PGRHTR1AADORA3 | |
| Muramyldipeptide SCHEMBL9231355 | 1.00 | NOD2 (1.00) | NOD2ESR1PGRHTR1AADORA3 | |
| Muramyldipeptide SCHEMBL17299289 | 1.00 | NOD2 (1.00) | NOD2ESR1PGRHTR1AADORA3 | |
| Muramyl Dipeptide SCHEMBL769016 | 0.99 | NOD2 (0.98) | NOD2ESR1PGRHTR1AADORA3 | |
| SCHEMBL16802190 | 0.94 | NOD2 (0.88) | NOD2ESR1PGRHTR1AADORA3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 23740 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122075695-A | Application of CYLD as marker in preparation of intervention product for early-birth infant late-onset sepsis | — | 2026-05-26 | — | — | CN | claimed |
| CN-122031666-A | Application of recombinant DL-endopeptidase and metabolite thereof in preparation of medicine for preventing premature infant late-onset septicemia | 南方医科大学珠江医院 | 2026-05-15 | — | — | CN | claimed |
| US-20260115281-A1 | TRITERPENE SAPONIN ANALOGUES | ADJUVANCE TECH INC (US) | 2026-04-30 | — | — | US | claimed |
| US-12611448-B2 | Targeting delivery system loaded with whole-cell components and use thereof | Suzhou Ersheng Biopharmaceutical Co., Ltd (CN) | 2026-04-28 | — | — | US | claimed |
| US-12611452-B2 | Foot-and-mouth disease virus-like particle antigen, vaccine composition, preparation method, and use thereof | PULIKE BIOLOGICAL ENGINEERING INC. (CN) | 2026-04-28 | — | — | US | claimed |
| US-20260108454-A1 | Innate Targeting of Adoptive Cellular Therapies | QU BIOLOGICS INC (CA) | 2026-04-23 | — | — | US | claimed |
| EP-4713015-A1 | SURFACE DISPLAY OF IMMUNOTHERAPEUTICS ON EXTRACELLULAR VESICLES AND USES THEREOF | National University of Singapore (SG) | 2026-03-25 | — | — | EP | claimed |
| US-12582711-B2 | RNA-based adjuvant to enhance the immune response to vaccines and therapeutics | ImmuneSure LLC (US) | 2026-03-24 | — | — | US | claimed |
| US-20260069672-A1 | Porcine Circovirus Type 3 (PCV3) Vaccines, and Production and Uses Thereof | BOEHRINGER INGELHEIM VETMEDICA GMBH (DE) | 2026-03-12 | — | — | US | claimed |
| US-12551545-B2 | African swine fever virus chimeric protein, vaccine composition, preparation method and use thereof | PULIKE BIOLOGICAL ENGINEERING INC (CN) | 2026-02-17 | — | — | US | claimed |
| EP-0276278-A1 | CHIMERIC PEPTIDES FOR NEUROPEPTIDE DELIVERY THROUGH THE BLOOD-BRAIN BARRIER. | UNIV CALIFORNIA (US) | 1988-08-03 | — | — | EP | claimed |
| WO-1988000834-A1 | CHIMERIC PEPTIDES FOR NEUROPEPTIDE DELIVERY THROUGH THE BLOOD-BRAIN BARRIER | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 1988-02-11 | — | — | WO | claimed |
| US-4711842-A | FUSING MACROPHAGE TUMOR CELL LINE WITH NON-TUMOR MACROPHAGE; INTERLEUKIN-1 PRODUCED | ASAHI KASEI KOGYO KABUSHIKI KAISHA (JP) | 1987-12-08 | — | — | US | claimed |
| US-4652449-A | Encapsulating biological active substances into erythrocytes | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) (FR) | 1987-03-24 | — | — | US | claimed |
| EP-0192671-A4 | MINACTIVIN. | BIOTECH AUSTRALIA PTY LTD (AU) | 1987-01-22 | — | — | EP | claimed |
| EP-0192671-A1 | MINACTIVIN. | BIOTECH AUSTRALIA PTY LTD (AU) | 1986-09-03 | — | — | EP | claimed |
| EP-0179791-A1 | A PHARMACEUTICAL PRODUCT HAVING AN ANTI-TUMOR ACTIVITY; THE USE OF A PHARMACEUTICAL PRODUCT OR OF PHARMACEUTICAL COMPOSITIONS IN AN ANTI-TUMOR THERAPY | Rijksuniversiteit Utrecht (NL) | 1986-05-07 | — | — | EP | claimed |
| WO-1986001212-A1 | MINACTIVIN | BIOTECHNOLOGY AUSTRALIA PTY. LTD. (AU) | 1986-02-27 | — | — | WO | claimed |
| WO-1985004807-A1 | A PHARMACEUTICAL PRODUCT HAVING AN ANTI-TUMOR ACTIVITY; THE USE OF A PHARMACEUTICAL PRODUCT OR OF PHARMACEUTICAL COMPOSITIONS IN AN ANTI-TUMOR THERAPY | RIJKSUNIVERSITEIT UTRECHT (NL) | 1985-11-07 | — | — | WO | claimed |
| EP-0094997-A1 | Bovine mastitis vaccine, process for preparing it, and method for detecting efficacy thereof | CORNELL RESEARCH FOUNDATION, INC. (US) | 1983-11-30 | — | — | EP | claimed |